T1	Spec 0 10	Evaluation
T2	SNP 14 32	genetic variations
T3	Entity 36 55	miRNA-binding sites
T4	Entity 59 64	BRCA1
T5	Entity 69 74	BRCA2
R1	SNP_location Arg1:T2 Arg2:T3	
R2	SNP_coupled_gene Arg1:T2 Arg2:T4	
R3	SNP_coupled_gene Arg1:T2 Arg2:T5	
T6	Association 84 96	risk factors
E1	Association:T6 bc:T7 bc2:T8 snp_int:T2
T7	Cancer 120 131;148 161	early-onset breast cancer
T8	Cancer 139 161	familial breast cancer
A1	Cancer_Type T8 Familial
A2	Cancer_Type T7 Other
R4	Speculation_marker Arg1:E1 Arg2:T1	
T9	Entity 596 618	3' untranslated region
T10	Entity 620 625	3'UTR
R5	Equiv Arg1:T10 Arg2:T9	
T11	SNP 627 640	polymorphisms
R6	SNP_location Arg1:T11 Arg2:T10	
A3	SNP_Type T11 Non-Coding
A4	SNP_Type T2 Non-Coding
T12	Effect_Type 641 651	disrupting
T13	Entity 652 660	microRNA
T14	Entity 662 667	miRNA
R7	Equiv Arg1:T14 Arg2:T13	
T15	Gene_Regulation 662 667;669 676	miRNA binding
E2	Gene_Regulation:T15 Agent:T11
R8	Effect_type_marker Arg1:E2 Arg2:T12	
T16	Other_effect 684 694	functional
E3	Other_effect:T16 Agent:T11
T17	Spec 677 683	can be
R9	Speculation_marker Arg1:E3 Arg2:T17	
T18	Other_effect 710 725	genetic markers
E4	Other_effect:T18 Theme:T19
T19	Entity 729 735	cancer
T20	Spec 699 706	can act
R10	Speculation_marker Arg1:E4 Arg2:T20	
T21	Spec 754 763	determine
T22	SNP 764 781	genetic variation
T23	Entity 789 794	3'UTR
R11	SNP_location Arg1:T22 Arg2:T23	
T24	Entity 798 803	BRCA1
T25	Entity 804 809	BRCA2
R12	SNP_coupled_gene Arg1:T22 Arg2:T24	
R13	SNP_coupled_gene Arg1:T22 Arg2:T25	
T26	Cancer 813 821;838 851	familial breast cancer
A5	Cancer_Type T26 Familial
T27	Cancer 826 851	early-onset breast cancer
A6	SNP_Type T22 Non-Coding
T28	Association 754 763	determine
E5	Association:T28 snp_int:T22 bc:T26 bc2:T27
R14	Speculation_marker Arg1:E5 Arg2:T21	
T29	Entity 861 865;878 909	with mutations in the coding regions
T31	Entity 870 909	without mutations in the coding regions
R15	Risk_Factor Arg1:T22 Arg2:T29	
R16	Risk_Factor Arg1:T22 Arg2:T31	
T32	Entity 951 956	3'UTR
T33	SNP 957 965	variants
R17	SNP_location Arg1:T33 Arg2:T32	
A7	SNP_Type T33 Non-Coding
T34	Other_effect 995 1013	cancer development
E6	Other_effect:T34 Agent:T33
T35	Spec 971 977	may be
R18	Speculation_marker Arg1:E6 Arg2:T35	
T30	SNP 1260 1270	c.*1287C>T
T36	SNP 1272 1279	rs12516
R19	Equiv Arg1:T36 Arg2:T30	
T37	Entity 1282 1287	BRCA1
R20	SNP_coupled_gene Arg1:T36 Arg2:T37	
T38	Entity 1267 1270	C>T
R21	Nucleotide_substitution Arg1:T36 Arg2:T38	
T39	Entity 1263 1267	1287
R22	SNP_location Arg1:T36 Arg2:T39	
T40	SNP 1304 1311	rs15869
T41	Entity 1296 1299	105
T42	Entity 1299 1302	A>C
R23	Nucleotide_substitution Arg1:T40 Arg2:T42	
R24	SNP_location Arg1:T40 Arg2:T41	
T43	Entity 1314 1319	BRCA2
R25	SNP_coupled_gene Arg1:T40 Arg2:T43	
T45	Entity 1674 1679	BRCA1
T46	SNP 1698 1708	c.*1287C>T
T47	SNP 1710 1717	rs12516
R26	Equiv Arg1:T47 Arg2:T46	
T48	Entity 1701 1705	1287
T49	Entity 1705 1708	C>T
R27	Nucleotide_substitution Arg1:T47 Arg2:T49	
R28	SNP_location Arg1:T47 Arg2:T48	
R29	SNP_coupled_gene Arg1:T47 Arg2:T45	
T50	Entity 1723 1738	BRCA1 mutations
R30	Risk_Factor Arg1:T47 Arg2:T50	
T51	SNP 1789 1796	rs12516
T52	SNP 1777 1787	c.*1287C>T
R31	Equiv Arg1:T51 Arg2:T52	
T53	Entity 1805 1810	BRCA1
R32	SNP_coupled_gene Arg1:T51 Arg2:T53	
T54	Effect_Type 1865 1874	increased
T55	Association 1875 1879	risk
E7	Association:T55 bc:T56 snp_int:T51
A8	Effect_Type E7 Increase
R33	Effect_type_marker Arg1:E7 Arg2:T54	
T56	Cancer 1894 1907	breast cancer
T57	Entity 1784 1787	C>T
T58	Entity 1780 1783	128
R34	SNP_location Arg1:T51 Arg2:T58	
R35	Nucleotide_substitution Arg1:T51 Arg2:T57	
A9	SNP_Type T51 Non-Coding
A10	SNP_Type T47 Non-Coding
T59	Other_effect 1990 1998	function
E8	Other_effect:T59 Theme:T60 Agent:T51
T60	Entity 1984 1989	BRCA1
T61	Spec 1912 1918	likely
R36	Speculation_marker Arg1:E8 Arg2:T61	
T62	Effect_Type 2012 2021	increased
T63	Entity 2076 2094	Turkish population
R37	Population_assignment Arg1:T51 Arg2:T63	
R38	Population_assignment Arg1:T47 Arg2:T63	
T44	Cancer 2022 2033;2050 2063	early-onset breast cancer
A11	Cancer_Type T44 Other
T64	Association 2064 2068	risk
E9	Association:T64 snp_int:T51 bc:T44 bc2:T65
A12	Effect_Type E9 Increase
R39	Effect_type_marker Arg1:E9 Arg2:T62	
T65	Cancer 2041 2063	familial breast cancer
A13	Cancer_Type T65 Familial
